Viewing Study NCT02781467


Ignite Creation Date: 2025-12-25 @ 12:41 AM
Ignite Modification Date: 2026-02-28 @ 2:49 AM
Study NCT ID: NCT02781467
Status: TERMINATED
Last Update Posted: 2020-07-22
First Post: 2016-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
Sponsor: Celularity Incorporated
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid View
None Leukemia View
None PNK-007 View
None Human IL-2 View
None RHIL-2 View
None Fludarabine View
None Cyclophosphamide View